January 12-15, 2026 | San Francisco Marriott Marquis, CA
Ilimis Therapeutics is a platform-based biotech company developing a chimeric fusion protein platform (GAIA) for Neurodegenerative/Immune diseases. GAIA is differentiated by its ability to address the concern of antibody-induced neuroinflammation.